Society guideline links: Testosterone therapy in men

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Male infertility or hypogonadism" and "Society guideline links: Male sexual dysfunction".)

International

●Endocrine Society (ES): Clinical practice guideline on testosterone therapy in men with hypogonadism (2018)

Canada

●Choosing Wisely Canada: Don't order serum testosterone in men without symptoms of hypogonadism (updated 2020)

●Choosing Wisely Canada: Don't prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency (updated 2020)

●Canadian Men's Health Foundation (CMHF): Diagnosis and management of testosterone deficiency syndrome in men – Clinical practice guideline (2015)

United States

●American Urological Association (AUA): Guidelines for the evaluation and management of testosterone deficiency (2018)

●Choosing Wisely: Don't prescribe testosterone to men with erectile dysfunction who have normal testosterone levels (2013, updated 2018)

●American College of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE): Position statement on the association of testosterone and cardiovascular risk (2015)

●Choosing Wisely: Don't prescribe testosterone or testosterone products to men contemplating/attempting to initiate pregnancy (2015)

●US Food and Drug Administration (FDA): Testosterone information (updated 2015)

●Choosing Wisely: Don't prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency (2013)

Europe

●European Academy of Andrology (EAA): Guidelines on Klinefelter syndrome (2021)

●European Association of Urology (EAU): Guidelines on sexual and reproductive health (2018)

●European Menopause and Andropause Society (EMAS): Position statement on testosterone replacement therapy in the aging male (2016)

United Kingdom

●British Society for Sexual Medicine (BSSM): Guidelines on adult testosterone deficiency, with statements for UK practice (2017)

Australia-New Zealand

●Choosing Wisely Australia: Don't prescribe testosterone therapy unless there is evidence of proven testosterone deficiency

●Endocrine Society of Australia (ESA): Position statement on male hypogonadism (part 1) – Assessment and indications for testosterone therapy (2016)

●ESA: Position statement on male hypogonadism (part 2) – Treatment and therapeutic considerations (2016)

Japan

●The Japanese Urological Association (JUA)/Japanese Society for the Study of the Aging Male (JSSAM): Clinical practice manual for late-onset hypogonadism syndrome (2008)